Global Peripheral Intravenous (IV) Catheter Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

Get Exclusive Sample PDF of this Report Here

Peripheral Intravenous (IV) Catheter Market Analysis

• Peripheral intravenous (IV) catheters are essential medical devices used for the administration of fluids, medications, and nutrients directly into the bloodstream, commonly employed in hospitals and outpatient settings
• The demand for these devices is significantly driven by the increasing prevalence of chronic diseases, growing surgical procedures, and rising hospital admissions globally
• North America is expected to dominate the peripheral intravenous (IV) catheter market with a market share of 38.5%, due to robust healthcare infrastructure, widespread use of IV therapy in chronic disease management, and strong adoption of technologically advanced catheter solutions
• Asia-Pacific is expected to be the fastest growing region in the peripheral intravenous (IV) catheter market with a market share of 22.4%, during the forecast period due to increasing healthcare expenditure, rising patient awareness, and expanding access to IV therapy across both urban and rural regions
• Conventional PIVC segment is expected to dominate the market with a market share of 71.3% due to its widespread clinical adoption, lower cost compared to safety catheters, and ease of use in routine medical procedures

Report Scope and Peripheral Intravenous (IV) Catheter Market Segmentation

Get Exclusive Sample PDF of this Report Here

Peripheral Intravenous (IV) Catheter Market Trends

“Technological Advancements and Safety Features Enhancing IV Catheter Adoption”

• One prominent trend in the peripheral IV catheter market is the growing adoption of safety-engineered devices that reduce the risk of needlestick injuries and catheter-related complications
• These innovations incorporate safety mechanisms such as retractable needles, blood control technology, and closed IV catheter systems, which improve both healthcare worker safety and patient care

• For instance, safety PIVCs with integrated blood control features prevent blood exposure during insertion, reducing infection risks and supporting compliance with occupational safety guidelines

• These advancements are reshaping clinical practice standards, driving the shift toward more secure, efficient intravenous therapy systems, and fueling demand for next-generation PIVCs globally

Peripheral Intravenous (IV) Catheter Market Dynamics

Driver

“Rising Hospital Admissions and Chronic Disease Burden”

• The growing prevalence of chronic conditions such as cancer, kidney diseases, cardiovascular disorders, and diabetes is significantly contributing to the rising demand for peripheral IV catheters
• As these conditions often require frequent hospitalizations and long-term intravenous therapies, the utilization of PIVCs in treatment settings continues to expand globally
• As global healthcare systems shift toward preventive care and remote monitoring, smart lenses are becoming essential tools that empower patients to manage their conditions more effectively

For instance,

• According to the World Health Organization (WHO), noncommunicable diseases (NCDs) account for approximately 74% of all global deaths, with many requiring hospitalizations and IV therapies as part of their management 
• As chronic diseases continue to rise globally, especially among aging populations, the demand for peripheral IV catheters increase, supporting safer and more effective patient care through reliable vascular access solutions

Opportunity

“Integration of Advanced Technologies for Enhanced Safety and Efficiency”

• The integration of advanced technologies such as blood control features, real-time vein visualization systems, and antimicrobial coatings presents a significant opportunity to improve the safety and efficacy of peripheral IV catheters
• These innovations not only minimize complications such as phlebitis, infiltration, and bloodstream infections but also improve first-attempt insertion success rates, reducing patient discomfort and healthcare costs
• In addition, the use of integrated/closed IV catheter systems enhances infection control by minimizing exposure to contaminants, making them increasingly favorable in high-acuity settings

For instance,

• According to a study published in The Journal of Hospital Infection (2024), the use of closed PIVC systems resulted in a 35% reduction in catheter-related bloodstream infections compared to conventional systems, supporting their growing adoption in hospitals globally 
• These technology-driven improvements create new growth avenues for manufacturers, offering healthcare providers smarter, safer, and more efficient IV therapy solutions, ultimately leading to better patient outcomes and greater operational efficiency

Restraint/Challenge

“Risk of Catheter-Related Complications and Needlestick Injuries”

• One of the major challenges restraining the peripheral IV catheter market is the risk of catheter-related complications such as phlebitis, infiltration, bloodstream infections, and needlestick injuries, which can lead to increased morbidity and healthcare costs
• Improper insertion techniques, extended dwell times, and lack of adherence to aseptic protocols can contribute to these complications, limiting widespread adoption and increasing the need for staff training and vigilance
• Despite advancements in catheter design, ensuring consistent safety practices and infection control across diverse healthcare settings—especially in resource-constrained environments—remains a hurdle

For instance,

• A study published by the Journal of Vascular Access in 2023 reported that up to 25% of peripheral IV catheters fail due to complications such as infiltration and phlebitis, leading to repeated insertions and patient discomfort, as well as increased treatment costs 
• These safety concerns can impact patient trust, prolong hospital stays, and drive hesitancy among healthcare providers, particularly in settings where training or resources are limited—ultimately challenging the sustained growth of the market

Peripheral Intravenous (IV) Catheter Market Scope

The market is segmented on the basis of product type, technology, application, and end user.

Get Exclusive Sample PDF of this Report Here

In 2025, the conventional PIVC is projected to dominate the market with a largest share in technology segment

The conventional PIVC segment is expected to dominate the peripheral intravenous (IV) catheter market with the largest share of 71.3% in 2025 due to its widespread clinical adoption, lower cost compared to safety catheters, and ease of use in routine medical procedures. These catheters remain the preferred choice in many healthcare settings, especially in resource-limited environments, where affordability and availability are key decision factors

The short peripheral IV catheters is expected to account for the largest share during the forecast period in product type market

In 2025, the short peripheral IV catheters segment is expected to dominate the market with the largest market share of 70.2% due to its ease of insertion, cost-effectiveness, and suitability for short-term therapies across various clinical settings. These catheters are widely used in emergency and inpatient care due to their quick access capabilities and lower complication rates, making them a preferred choice in both developed and developing healthcare systems.

Peripheral Intravenous (IV) Catheter Market Regional Analysis

“North America Holds the Largest Share in the Peripheral Intravenous (IV) Catheter Market”

• North America dominates the peripheral intravenous (IV) catheter market with a market share of estimated 38.5%, driven, by robust healthcare infrastructure, widespread use of IV therapy in chronic disease management, and strong adoption of technologically advanced catheter solutions
• U.S. holds a market share of 37.3%, due to the high volume of hospital admissions, growing geriatric population, and favorable reimbursement environment for IV therapy procedures
• The consistent rise in cancer, renal diseases, and cardiovascular conditions, along with increasing use of home healthcare services, continues to support the region’s dominant position in the market
• In addition, the presence of key manufacturers, rigorous infection control standards, and ongoing innovations in safety catheter technologies contribute to the region’s market leadership

“Asia-Pacific is Projected to Register the Highest CAGR in the Peripheral Intravenous (IV) Catheter Market”

• Asia-Pacific is expected to witness the highest growth rate in the peripheral intravenous (IV) catheter market with a market share of 22.4%, driven by increasing healthcare expenditure, rising patient awareness, and expanding access to IV therapy across both urban and rural regions
• Countries such as China, India, and Japan are at the forefront of market growth due to their large populations, rising prevalence of chronic and infectious diseases, and investments in modernizing healthcare delivery
• Japan continues to lead in the integration of advanced IV catheter systems, with strong emphasis on safety and infection prevention in clinical settings
• India is projected to register the highest CAGR of 7.7% in the peripheral intravenous (IV) catheter market, driven by government healthcare initiatives, growing number of hospital and diagnostic centers, and increased demand for cost-effective and efficient IV therapy solutions

Peripheral Intravenous (IV) Catheter Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

The Major Market Leaders Operating in the Market Are:

• BD (U.S.)
• B. Braun SE (German)
• Terumo Corporation (Japan)
• Vygon SAS (France)
• ICU Medical, Inc. (U.S.)
• Vogt Medical Vertrieb GmbH (Germany)
• RenovoRx (U.S.)
• Retractable Technologies, Inc. (U.S.)
• NIPRO (Japan)
• MedSource Labs. (U.S.)
• Argon Medical Device (U.S.)
• intra special catheters GmbH (Germany)
• Greiner Bio-One International GmbH (Austria)
• Medical Components, Inc. (U.S.)
• Ares Medikal (Turkey)
• ACE MEDICAL COMPANY (U.S.),
• Merit Medical Systems (U.S.)
• Heka s.r.l, (Italy)
• RAUMEDIC AG (Germany)
• Teleflex Incorporated (U.S.)

Latest Developments in Global Peripheral Intravenous (IV) Catheter Market

• In November 2023, BD introduced PIVO Pro, a needle-free blood draw device compatible with integrated and long peripheral IV catheters, including the Nexiva Closed IV Catheter System. This innovation aims to enhance patient comfort by reducing needlesticks and improving clinical outcomes, aligning with BD's vision of a "One-Stick Hospital Stay"
• In October 2023, B. Braun expanded its Peripheral Advantage Program to address health inequities in vascular access. This initiative focuses on empowering healthcare providers and improving patient experiences with intravenous therapies, advocating for enhanced standards of care
• In April 2023, BD launched the BD Prevue II System, an advanced ultrasound device equipped with a specialized probe and real-time needle depth markers. Designed to optimize IV placement, this system provides high-quality ultrasound images of needle trajectories, aiming to improve first-attempt success rates in IV insertions
• In March 2022, Shockwave Medical Inc. announced that its Shockwave M5+ peripheral IVL catheter, having received FDA approval and CE Mark, is now commercially available worldwide. The M5+ catheter is designed to enhance IVL treatments by offering additional access options and extending therapy to patients with larger vessel diameters
• In July 2022, B. Braun introduced the Introcan Safety 2 IV Catheter, featuring one-time blood control technology. This innovation aims to increase safety for clinicians by reducing the risk of blood exposure and needlestick injuries during IV access procedures

SKU-21780